CRT Meeting

02/21/2026

Cardiovascular Research Technologies (CRT) returns to the Washington Hilton Hotel Saturday, March 7, through Tuesday, March 10, in Washington, D.C., for another year of premier interventional cardiology sessions, industry collaboration, late-breaking clinical research and more. Read all about CRT 2026 on CRTonline.

Cardiovascular Research Technologies (CRT) returns to the Washington Hilton Hotel Saturday, March 7, through Tuesday, March 10, in Washington, DC, for another year of premier interventional cardiology

02/21/2026

If you're part of a heart team, you belong at CRT 💙 CRT 2026 brings together all those in cardiovascular medicine for 4 days of ideas, discussions and sessions to improve patient care. Register today on CRTmeeting.org 💙🫀💻

02/20/2026

A new application of balloon-assisted translocation of the mitral anterior leaflet (BATMAN) has achieved a redo transcatheter mitral valve replacement in a high-risk valve-in-mitral annular calcification case, according to a new case report. Read more on CRTonline.

A new application of balloon-assisted translocation of the mitral anterior leaflet (BATMAN) has achieved a redo transcatheter mitral valve replacement (TMVR) in a high-risk valve-in-mitral annular cal

02/20/2026

A variety of 📸 Spotlight Sessions 🔦 will be featured at CRT 2026, including topics like radiation protection, structural heart mastery, TAV-in-TAV, roundtables with editors and "Wall Street" and more! Save your seat today on CRTmeeting.org 🫀

02/19/2026

Attend CRT 2026 and be part of the largest chronic total occlusions (CTO) course in the U.S.! Reserve your spot today on CRTmeeting.org 🩺🫀

02/19/2026

Research shows the practice of baduanjin lowers systolic blood pressure (SBP) after 3 months of consistency in people with high-normal BP levels, and this effect continues for a year even after discontinuation of the practice. Read more on CRTonline.

The practice of baduanjin lowers systolic blood pressure (SBP) after 3 months of consistency in people with high-normal BP levels, and this effect continues for a year even after discontinuation of th

02/18/2026

Older patients with heart failure with reduced ejection fraction (HFrEF) are at significantly higher risk of death and hospital readmission for heart failure even after being prescribed quadruple medical therapy for treatment, a cohort study shows. Read more on CRTonline.

Older patients with heart failure with reduced ejection fraction (HFrEF) are at significantly higher risk of death and hospital readmission for heart failure even after being prescribed quadruple medi

02/18/2026

Owen Faris, Deputy Center Director for Regulatory Operations at the Center for Devices and Radiological Health in the U.S. Food and Drug Administration (FDA), will be front and center as our MedTech and Regulatory Science Keynote at CRT 2026. Come eager to learn and discuss ➡️ CRTmeeting.org

02/17/2026

✨NEW✨ at CRT 2026, we're bringing electrophysiology front and center. Some sessions include the intersection of heart failure and electrophysiology, left atrial appendage occlusion and abstracts. Go to CRTmeeting.org for the full agenda and registration 💛

02/17/2026

Rates of all-cause death or disabling stroke are similar long-term in patients with aortic stenosis (AS) who undergo transcatheter aortic valve replacement (TAVR) versus surgery, and patients who receive TAVR have higher rates of reintervention, 6-year results from the Evolut Low Risk trial show. Read more on CRTonline.

Rates of all-cause death or disabling stroke are similar long-term in patients with aortic stenosis (AS) who undergo transcatheter aortic valve replacement (TAVR) versus surgery, and patients who rece

02/16/2026

Join us for heavy vests, high stakes and hot takes with women in interventional cardiology 🫀 at CRT 2026, hosted by Suzanne Baron, MD, MPH. Grab a bite to eat and listen in on this important discussion 💝🔗 Go to CRTmeeting.org to save your spot 💝

02/16/2026

Hemolytic anemia occurs approximately 10 times more frequently with fifth-generation SAPIEN 3 Ultra RESILIA (S3UR) valves than with the third-generation SAPIEN 3 (S3), despite the newer valve showing less paravalvular leak, an analysis of data from Japanese patients suggests. Read more on CRTonline.

Hemolytic anemia occurs approximately 10 times more frequently with fifth-generation SAPIEN 3 Ultra RESILIA (S3UR) valves than with the third-generation SAPIEN 3 (S3), despite the newer valve showing